
By-health Co., Ltd.
VDS
By-health Co., Ltd. is China's pioneer and market leader in the vitamin and dietary supplement (VDS) non-direct-sales channel, listed on the Shenzhen Stock Exchange (300146.SZ) and headquartered in Zhuhai, Guangdong. The company generated approximately CNY 6.27 billion in annual revenue in 2025, facing macro consumer weakness and channel migration to live-stream e-commerce. Its 40,000 sqm Transparent Factory 3.0 in Zhuhai - built at a cost of CNY 420 million - features over 200 sets of globally sourced automated equipment, China's first pneumatic rail logistics system, and annual production capacity of 5 billion tablets, 3 billion softgels, and 500 million hard capsules. By-health was the first Chinese company to open its manufacturing facility to public supervision, having received over 2 million visitors since inception.
Strengths: (1) Industry-leading transparent factory with full public audit access builds unparalleled consumer trust and quality credibility; (2) Massive production scale of 5 billion tablets and 3 billion softgels - the largest non-direct-sales VDS manufacturing capacity in China; (3) Global ingredient sourcing model featuring 20+ countries with full supply chain transparency; (4) Pioneering AI-powered Multi-Dimensional Homeostasis Health Evaluation System in development for next-generation personalized nutrition; (5) First Chinese VDS company to adopt comprehensive third-party manufacturing transparency standards.
Weaknesses: (1) Revenue decline of 8.4-20% reflects intense competitive pressure from live-stream e-commerce channels; (2) Net profit down 17.34% in H1 2025 amid macro consumer spending headwinds; (3) Heavy investment in Transparent Factory 3.0 creates fixed cost burden during revenue contraction.Read More ▼Show Less ▲
Strengths: (1) Industry-leading transparent factory with full public audit access builds unparalleled consumer trust and quality credibility; (2) Massive production scale of 5 billion tablets and 3 billion softgels - the largest non-direct-sales VDS manufacturing capacity in China; (3) Global ingredient sourcing model featuring 20+ countries with full supply chain transparency; (4) Pioneering AI-powered Multi-Dimensional Homeostasis Health Evaluation System in development for next-generation personalized nutrition; (5) First Chinese VDS company to adopt comprehensive third-party manufacturing transparency standards.
Weaknesses: (1) Revenue decline of 8.4-20% reflects intense competitive pressure from live-stream e-commerce channels; (2) Net profit down 17.34% in H1 2025 amid macro consumer spending headwinds; (3) Heavy investment in Transparent Factory 3.0 creates fixed cost burden during revenue contraction.
Business Nature
Core Business Areas
Industry Rankings
Corporate Report
VerityRank Score
Based on market presence, financial scale, operational capacity, and brand strength.
Quick Facts
Headquarters
Zhuhai, Guangdong
Founded
1995
Employees
2,867
Factories
Zhuhai, Guangdong, China (Transparent Factory 3.0: 40,000 sqm facility)
Listing
Listed - SZSE (300146.SZ)
Categories
Data Sources & Methodology
This corporate profile is compiled from publicly available sources including company annual reports, SEC/regulatory filings, official press releases, and verified third-party industry databases. Financial figures reflect the most recent fiscal year disclosures and are cross-validated across multiple independent references.
VerityRank Score is calculated using a proprietary multi-dimensional model evaluating market presence, financial strength, operational scale, innovation capacity, and brand influence. Individual dimension scores are normalized against industry peers and updated quarterly.
Disclaimer: This profile is for informational purposes only. VerityRank makes no warranties regarding completeness or timeliness. This content does not constitute investment advice or endorsement.
Key references: Official Website , By-health Stock Price - Futunn, By-health Revenue - Investing.com, Transparent Factory - BYHEALTH
